Related Experiment Video
Updated: Sep 5, 2025
03:05
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
1.2K
Progression risk factors of ulcerative proctitis
Katarzyna Gaweł1, Krzysztof Dąbkowski1, Iwona Zawada1
1Department of Gastroenterology, Pomeranian Medical University, Szczecin, Poland.
Scandinavian Journal of Gastroenterology
|July 6, 2022
Summary
Ulcerative proctitis (UP), a form of ulcerative colitis, generally has a good prognosis and responds well to topical treatments. Early identification of high-risk UP patients is crucial for preventing complications.
Area of Science:
- Gastroenterology
- Inflammatory Bowel Disease Research
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease with unknown causes, marked by flare-ups and remissions.
- Ulcerative proctitis (UP) affects 25-55% of UC patients at diagnosis and typically follows a less aggressive course than extensive UC.
- UP is associated with a favorable prognosis, good response to topical therapies, and lower risks of severe complications and colectomy.
Approach:
- This review synthesizes current knowledge on the natural history of ulcerative proctitis.
- It examines risk and protective factors influencing disease progression in UP.
- Current treatment strategies for UP are also discussed.
Key Points:
- Ulcerative proctitis presents a less severe disease course compared to left-sided UC and pancolitis.
- Patients with UP generally exhibit a better response to topical treatments.
- UP is linked to reduced risks of severe exacerbations, complications, colectomy, and need for systemic medications.
Conclusions:
- Effective prognostication of UP's natural course is essential for identifying at-risk individuals.
- Timely intervention with advanced therapies, such as biologics or immunosuppressants, can prevent disease progression and complications.
- Understanding risk and protective factors guides personalized treatment approaches for ulcerative proctitis.
Related Concept Videos
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
305
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
305
01:30Peptic Ulcer Disease I: Introduction
275
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
275
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
516
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
516
01:17Chronic Bowel Disorders: Introduction
534
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
534
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
01:28Peptic Ulcer Disease II: Pathophysiology
801
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
801